Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease

Pathogenesis of Chagas' Disease: Parasite Persistence and Autoimmunity

(2011) A. R. L. Teixeira et al.   CLINICAL MICROBIOLOGY REVIEWS

ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas' disease

(2011) D. G. Strauss et al.   HEART

The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice

(2011) Andréa P de Souza et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism

(2011) Antonio R. L. Teixeira et al.   PLoS Neglected Tropical Diseases

Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction

(2010) Sih Min Tan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Endothelin 1 contributes to the effect of transforming growth factor β1 on wound repair and skin fibrosis

(2010) David Lagares et al.   ARTHRITIS AND RHEUMATISM

ThePlasmodiumeukaryotic initiation factor-2α kinase IK2 controls the latency of sporozoites in the mosquito salivary glands

(2010) Min Zhang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

ECG Detection of Murine Chagasic Cardiomyopathy

(2010) Christopher S. Eickhoff et al.   JOURNAL OF PARASITOLOGY

Gap junction reduction in cardiomyocytes following transforming growth factor-β treatment and Trypanosoma cruzi infection

(2010) Mariana C Waghabi et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity

(2010) Tanaka   ONCOLOGY REPORTS

Pharmacological Inhibition of Transforming Growth Factor   Signaling Decreases Infection and Prevents Heart Damage in Acute Chagas' Disease

(2009) M. C. Waghabi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tumor necrosis factor alpha induced by Trypanosoma cruzi infection mediates inflammation and cell death in the liver of infected mice

(2009) Maria T. Ronco et al.   CYTOKINE

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

(2009) J Antonio Marin-Neto et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Pivotal role for TGF-β in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy

(2008) Tania C. Araújo-Jorge et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis

(2007) M. Petersen et al.   KIDNEY INTERNATIONAL